Gila Bioscience is a Carlsbad-based CDMO specializing in end-to-end custom assay development and GMP-compliant manufacturing for clinical, veterinary, and biodefense markets, bridging the gap between concept and commercial diagnostics.
Gila Bioscience is a Contract Development and Manufacturing Organization (CDMO) based in Carlsbad, California, that specializes in end-to-end diagnostic solutions. The company provides custom assay development, regulatory consulting, and GMP-compliant manufacturing for various industries, including human health, veterinary, environmental, and biodefense sectors. Their services encompass feasibility studies, reagent development, prototyping, performance optimization, and scalable production, supporting clients from the initial concept phase through to commercial launch and regulatory submission. They leverage expertise in platforms such as lateral flow, ELISA, flow-through, and microfluidics.
Gila Bioscience serves as a dedicated partner for diagnostic companies and government programs, addressing the complex challenges of bringing accurate, high-performance point-of-care tests to market. By integrating design control, documentation, and regulatory navigation—aligned with FDA, USDA, and ISO 13485 standards—they ensure that products are built for reproducibility, clinical trial integration, and commercial scalability. With a team possessing decades of combined industry experience, the company assists partners in overcoming bottlenecks in assay robustness and manufacturing, ultimately helping to facilitate faster, safer, and more accessible diagnostic outcomes in real-world settings.